TickerFactsScreenerDevelopers

Keros Therapeutics, Inc. (KROS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$16.00M2020: -$36.89M2021: -$62.15M2022: -$70.06M2023: -$124.51M2024: -$160.87M2025: $107.50M$107.50M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$107.50M+166.8%
2024-$160.87M-29.2%
2023-$124.51M-77.7%
2022-$70.06M-12.7%
2021-$62.15M-68.5%
2020-$36.89M-130.6%
2019-$16.00M—